OTC Markets EXMKT - Delayed Quote USD

IR Biosciences Holdings, Inc. (IRBS)

Compare
0.0001
0.0000
(0.00%)
At close: January 30 at 3:00:00 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
Operating Expense
2,859.5760
Operating Income
-2,859.5760
Net Non Operating Interest Income Expense
-1,706.5020
Other Income Expense
-709.0360
Pretax Income
-5,282.3570
Tax Provision
-4.2130
Net Income Common Stockholders
-5,407.1440
Diluted NI Available to Com Stockholders
-5,407.1440
Basic EPS
-0.34
Diluted EPS
-0.34
Basic Average Shares
15,790.1840
Diluted Average Shares
15,790.1840
Total Operating Income as Reported
-2,859.5760
Total Expenses
2,859.5760
Net Income from Continuing & Discontinued Operation
-5,278.1440
Normalized Income
-4,569.6735
Interest Expense
1,706.5020
Net Interest Income
-1,706.5020
EBIT
-3,575.8550
EBITDA
-3,567.5240
Reconciled Depreciation
8.3310
Net Income from Continuing Operation Net Minority Interest
-5,278.1440
Total Unusual Items Excluding Goodwill
-709.0360
Total Unusual Items
-709.0360
Normalized EBITDA
-2,858.4880
Tax Rate for Calcs
0.0000
Tax Effect of Unusual Items
-0.5655
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers